How Suboxone Treatment Programs in West Virginia Coordinate With Primary Care Providers
Most people starting Suboxone don't stop needing a regular doctor. They still have blood pressure to manage, diabetes to monitor, infections to treat, and prescriptions that may interact with buprenorphine. That creates a problem: two providers, two medication lists, and no guarantee they're talking to each other.
In West Virginia, where provisional overdose deaths dropped 28% between early 2023 and 2024, the coordination between Suboxone programsx and primary care offices is one of the less visible reasons treatment is working better than it used to. Here's how that coordination actually happens.
It Starts With a Release and a Clear Division of Labor
Before any information moves between a Suboxone clinic and a primary care office, the patient signs a release of information. This isn't a formality. Under 42 CFR Part 2, substance use treatment records carry stricter privacy protections than standard medical records, so the consent has to specifically name who can share what.
Once that's in place, the two offices define their lanes. The Suboxone program handles buprenorphine prescribing, urine drug screens, and recovery-related counseling. Primary care handles everything else: chronic conditions, preventive screenings, vaccinations, referrals to specialists.
The overlap zone (sleep issues, anxiety, smoking cessation, pain management) is where coordination matters most. Without a clear agreement on who prescribes what, patients end up with conflicting medications or, worse, gaps where neither provider thinks the other one is handling it.
In community settings, clinics like Delta Lifestyle Solutions work to bridge this gap by maintaining direct communication channels with referring primary care providers, so patients moving between recovery care and routine medical visits aren't starting from scratch each time.
West Virginia's CSMP Creates a Built-In Safety Check
West Virginia's Controlled Substances Monitoring Program, administered by the Board of Pharmacy, requires prescribers to check the CSMP database before dispensing any Schedule II controlled substance, any opioid, or any benzodiazepine to a patient not in terminal care. After the initial check, prescribers must query the database at least annually for any patient continuing on a controlled substance.
On the pharmacy side, every controlled substance dispensed in West Virginia must be reported to the CSMP within 24 hours.
This matters for coordination because both the Suboxone prescriber and the primary care physician are looking at the same database. If a patient's primary care doctor prescribes a benzodiazepine for anxiety (which carries serious interaction risks with buprenorphine), the Suboxone provider will see it on the next CSMP check, and vice versa. It doesn't replace a phone call between offices, but it catches the situations where that phone call didn't happen.
The state expanded CSMP reporting in recent years to include opioid antagonists like naloxone, gabapentin, and pregabalin, plus non-fatal overdose reports. That broader data set gives both providers a more complete picture of what's happening with a shared patient.
Medication Reconciliation Happens More Than Once
In most healthcare settings, medication reconciliation is an intake task. You list everything you're taking, someone checks for conflicts, and it goes in the chart. In Suboxone treatment, it has to be an ongoing process.
Here's why: a patient might start a new antibiotic, get prescribed a steroid taper for an unrelated issue, or have a sleep aid added, all through primary care, all after the initial reconciliation. Any of those could increase sedation risk or complicate recovery.
Effective programs send a current medication list to primary care at regular intervals and ask for confirmation of what primary care is managing. Primary care sends back any changes. The goal is straightforward: identify combinations that increase fall risk, respiratory depression, or sedation, and flag them before they become emergencies.
Some programs take it a step further by coordinating pharmacy use. When a patient fills all prescriptions (buprenorphine and everything else) at a single pharmacy, the pharmacist becomes another layer of interaction screening.
Lab Work and Screening: Who Orders What
Suboxone programs and primary care offices often duplicate lab work simply because neither knows what the other has already ordered. Good coordination eliminates that.
A typical split looks like this:
Primary care handles: routine blood panels, infectious disease screening (Hepatitis C is common in this population), thyroid function, A1C for diabetic patients, vaccinations, and preventive care screenings
Suboxone programs handle: urine drug screens, treatment adherence monitoring, and buprenorphine-specific safety labs (liver function panels, particularly for patients with hepatitis or heavy prior alcohol use)
When a urine screen shows something unexpected (a new substance, or the absence of prescribed buprenorphine), the treatment program can share that with primary care in summary form. Not the raw result, but the clinical implication: "this changes the risk profile, adjust accordingly."
For patients with liver disease, pregnancy, or complex medication regimens, this coordination isn't optional. Primary care has the patient's full history of imaging, hospitalizations, and specialist visits. The Suboxone program has the recovery-specific context. Neither picture is complete alone.
Behavioral Health Gets Folded In
West Virginia has adopted versions of the hub-and-spoke model, where a central treatment program supports community clinics with consultation, training, and care management resources. This model, which helped 14 healthcare facilities begin offering buprenorphine treatment and trained 56 health professionals through initial state funding, makes it easier for primary care offices to participate in MAT without building a full addiction program from scratch.
Within this structure, behavioral health notes are typically shared with primary care in summary form (treatment goals, session attendance, and any safety concerns) rather than full session details. Primary care providers can reinforce those goals during regular visits: asking about sleep, stress management, and coping strategies without duplicating the counseling relationship.
Social determinants also get coordinated here. Transportation barriers, housing instability, and food insecurity all affect whether someone shows up for appointments and takes medication consistently. When a treatment program identifies these issues, looping in primary care means the patient isn't managing two separate sets of referrals to community resources.
Transitions Are Where Coordination Breaks Down or Proves Its Value
Hospital discharges, ER visits, insurance changes, and provider transitions are where patients fall through the cracks. Someone gets admitted for surgery, their buprenorphine gets held or discontinued by a hospitalist unfamiliar with MAT, and they're discharged with a gap in treatment and no follow-up plan.
Coordinated programs address this by:
Requesting discharge summaries within 48 hours to confirm whether buprenorphine was continued, paused, or replaced
Flagging acute pain situations in advance so the surgical or ER team has a plan that accounts for the patient's MAT status
Having primary care monitor new diagnoses, new medications, and follow-up compliance after a hospital stay, then relaying that information back to the treatment program
SAMHSA's guidance on integrating buprenorphine into primary care specifically notes that primary care providers play a significant role in managing OUD treatment long-term, particularly as patients stabilize and the Suboxone program steps back from frequent monitoring.
What This Means for Patients
None of this coordination is visible to the patient when it's working well. They show up to their primary care appointment and the doctor already knows what medications the Suboxone clinic prescribed. They get their blood drawn once instead of twice. Their pharmacy catches an interaction before they pick up a new prescription.
When it's not working, when the Suboxone provider and the primary care office aren't communicating, patients end up managing their own care coordination, relaying information between offices, hoping nothing gets lost. For someone in early recovery, that's an unreasonable burden.
West Virginia's infrastructure, from CSMP requirements to the hub-and-spoke model, creates the framework for coordination. But the actual work happens at the clinic level, between providers who commit to sharing information, defining roles, and treating the same patient as one person with connected needs rather than two separate charts.